SG10201606745XA - Therapeutics using adipose cells and cell secretions - Google Patents

Therapeutics using adipose cells and cell secretions

Info

Publication number
SG10201606745XA
SG10201606745XA SG10201606745XA SG10201606745XA SG10201606745XA SG 10201606745X A SG10201606745X A SG 10201606745XA SG 10201606745X A SG10201606745X A SG 10201606745XA SG 10201606745X A SG10201606745X A SG 10201606745XA SG 10201606745X A SG10201606745X A SG 10201606745XA
Authority
SG
Singapore
Prior art keywords
therapeutics
adipose cells
cell secretions
secretions
cell
Prior art date
Application number
SG10201606745XA
Other languages
English (en)
Inventor
Graham Vesey
Rebecca Anne Webster
Richard Lilischkis
Original Assignee
Cell Ideas Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011903938A external-priority patent/AU2011903938A0/en
Application filed by Cell Ideas Pty Ltd filed Critical Cell Ideas Pty Ltd
Publication of SG10201606745XA publication Critical patent/SG10201606745XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
SG10201606745XA 2011-09-23 2012-09-21 Therapeutics using adipose cells and cell secretions SG10201606745XA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2011903938A AU2011903938A0 (en) 2011-09-23 Therapeutic methods and compositions
AU2012901350A AU2012901350A0 (en) 2012-04-04 Therapeutic methods and compositions
AU2012903646A AU2012903646A0 (en) 2012-08-23 Therapeutic methods and compositions

Publications (1)

Publication Number Publication Date
SG10201606745XA true SG10201606745XA (en) 2016-10-28

Family

ID=47913679

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2014013676A SG2014013676A (en) 2011-09-23 2012-09-21 Therapeutics using adipose cells and cell secretions
SG10201606745XA SG10201606745XA (en) 2011-09-23 2012-09-21 Therapeutics using adipose cells and cell secretions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2014013676A SG2014013676A (en) 2011-09-23 2012-09-21 Therapeutics using adipose cells and cell secretions

Country Status (9)

Country Link
US (3) US10111909B2 (enrdf_load_stackoverflow)
EP (3) EP2744892B1 (enrdf_load_stackoverflow)
JP (5) JP6162123B2 (enrdf_load_stackoverflow)
AU (1) AU2012313352B2 (enrdf_load_stackoverflow)
CA (1) CA2885487C (enrdf_load_stackoverflow)
DK (2) DK2744892T3 (enrdf_load_stackoverflow)
ES (2) ES2880084T3 (enrdf_load_stackoverflow)
SG (2) SG2014013676A (enrdf_load_stackoverflow)
WO (1) WO2013040649A1 (enrdf_load_stackoverflow)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
US10111909B2 (en) * 2011-09-23 2018-10-30 Cell Ideas Pty Ltd Therapeutics using adipose cells and cell secretions
JP2023002772A (ja) * 2011-09-23 2023-01-10 レジニアス リミテッド 脂肪細胞および細胞分泌物を使用する治療
AU2013204930C1 (en) * 2012-09-26 2015-01-22 Cell Ideas Pty Ltd Therapeutics using multiple injections of cells
EP2919794B1 (en) 2012-11-15 2021-01-20 AlloSource Minced cartilage systems and methods
AU2013370932B2 (en) 2012-12-24 2019-02-21 Cell Ideas Pty Ltd Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
KR102215401B1 (ko) 2013-02-22 2021-02-10 알로소스 연골 모자이크 조성물 및 방법
KR102312720B1 (ko) 2013-03-15 2021-10-13 알로소스 연조직 회복 및 재생을 위한 세포 재배치된 콜라겐 매트릭스
AU2014236705B2 (en) 2013-03-15 2018-04-12 Allosource Perforated osteochondral allograft compositions
AU2014281818B2 (en) * 2013-06-19 2019-08-22 Spinalcyte, Llc Adipose cells for chondrocyte applications
KR20160073382A (ko) * 2013-10-04 2016-06-24 셀 아이디어스 피티와이 엘티디 세포 치료를 위한 바이오마커들
AU2015367275B2 (en) * 2014-12-19 2021-11-18 Cell Ideas Pty Ltd Improved cell therapies
WO2017041133A1 (en) 2015-09-08 2017-03-16 Cell Ideas Pty Ltd Cell expansion methods and therapeutic compositions
CN108289915A (zh) * 2015-11-24 2018-07-17 日本乐敦制药株式会社 包含脂肪组织来源基质细胞的肝病治疗剂及其制造方法
EP3478300B1 (en) 2016-06-30 2022-08-24 Stem Cell Medicine Ltd. Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
CN110709091A (zh) 2017-05-15 2020-01-17 干细胞医药有限公司 使用长效格拉替雷和脂肪源性干细胞治疗多发性硬化症
WO2018211498A1 (en) 2017-05-15 2018-11-22 Stem Cell Medicine Ltd. Treatment of multiple sclerosis with adipose-derived stem cells
CA3059319A1 (en) * 2017-10-02 2019-04-11 Hirotaro Fukuoka Pharmaceutical composition for use in improving quality of scalp or skin, wound healing, or improving quality of hair
KR20210021358A (ko) * 2018-06-15 2021-02-25 파르도 루이스 마리나스 약제학적 피부과 조성물 및 그 용도
US20210177909A1 (en) * 2018-08-14 2021-06-17 National Center For Global Health And Medicine Supernatant of brown adipocytes, method for preparing same and utilization thereof
JP7429032B2 (ja) * 2019-12-24 2024-02-07 学校法人順天堂 間質性肺炎モデル非ヒト動物の作製方法
JP6826744B1 (ja) * 2020-07-17 2021-02-10 医療法人Ｙａｎａｇａ ＣＬｉｎｉｃ 成熟脂肪細胞含有組成物の製造方法
CN114452303B (zh) * 2020-11-10 2025-05-30 上海萨美细胞技术有限公司 无细胞脂肪提取液对关节炎的治疗用途
IT202100003062A1 (it) * 2021-02-11 2022-08-11 Gaia Margiotta "processo di crioconservazione di tessuto adiposo"
CN115521908A (zh) * 2022-10-24 2022-12-27 潍坊天创生物科技有限公司 一种脂肪间充质干细胞的体外培养及外泌体的分离纯化方法
DE202023002795U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC System zur automatisierten Herstellung einer regenerativen epidermalen Suspension

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037175A (en) 1996-03-12 2000-03-14 The University Of South Florida Method and media for enhancing cryopreservation of cells
US7078232B2 (en) * 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
AU2002356935A1 (en) * 2001-11-09 2003-05-19 Artecel Sciences, Inc. Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
CN1630526B (zh) * 2001-12-07 2010-05-05 马克罗珀尔生物外科公司 用加工的脂肪抽吸细胞来治疗患者的系统和方法
WO2005035742A2 (en) * 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
US8715733B2 (en) * 2004-07-23 2014-05-06 DePuy Synthes Products, LLC Enhanced adipose tissue
JP5240715B2 (ja) * 2006-08-08 2013-07-17 国立大学法人名古屋大学 脂肪組織由来多分化能幹細胞を含有する細胞製剤
EP2076275B1 (en) 2006-10-06 2014-12-03 University Of Virginia Patent Foundation Compositions useful for diabetic wound healing
WO2009115581A2 (en) * 2008-03-19 2009-09-24 Cryo-Save Ag Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells
WO2009152084A2 (en) 2008-06-11 2009-12-17 Cell4Vet Llc Adipose tissue-derived stem cells for veterinary use
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
ES2479621T3 (es) * 2009-04-28 2014-07-24 Anterogen Co., Ltd. Composición de células madre estromales derivadas de tejido adiposo autólogo y alogénico destinada al tratamiento de fístulas
US20120201791A1 (en) * 2009-10-15 2012-08-09 Tai June Yoo Methods of treating diseases or conditions using mesenchymal stem cells
DK3156060T3 (da) * 2011-03-15 2019-11-25 Cell Ideas Pty Ltd Farmaceutiske sammensætninger og topisk anvendelse deraf
US10111909B2 (en) 2011-09-23 2018-10-30 Cell Ideas Pty Ltd Therapeutics using adipose cells and cell secretions

Also Published As

Publication number Publication date
ES2721180T3 (es) 2019-07-29
WO2013040649A1 (en) 2013-03-28
US20190015455A1 (en) 2019-01-17
JP6912512B2 (ja) 2021-08-04
US10660921B2 (en) 2020-05-26
JP6839038B2 (ja) 2021-03-03
EP2744892B1 (en) 2019-03-20
US10111909B2 (en) 2018-10-30
US20200261510A1 (en) 2020-08-20
EP3546569B1 (en) 2021-06-16
JP6162123B2 (ja) 2017-07-12
JP2017193566A (ja) 2017-10-26
AU2012313352A1 (en) 2013-05-02
CA2885487C (en) 2021-11-16
JP2014527821A (ja) 2014-10-23
JP2021155461A (ja) 2021-10-07
US20140234272A1 (en) 2014-08-21
DK2744892T3 (en) 2019-04-23
JP2022033865A (ja) 2022-03-02
JP2019142971A (ja) 2019-08-29
EP2744892A1 (en) 2014-06-25
AU2012313352B2 (en) 2015-07-02
EP3546569A1 (en) 2019-10-02
JP7022863B2 (ja) 2022-02-18
SG2014013676A (en) 2014-05-29
ES2880084T3 (es) 2021-11-23
EP3868871A1 (en) 2021-08-25
AU2012313352A9 (en) 2013-09-26
CA2885487A1 (en) 2013-03-28
EP2744892A4 (en) 2015-05-20
DK3546569T3 (da) 2021-07-12

Similar Documents

Publication Publication Date Title
SG10201606745XA (en) Therapeutics using adipose cells and cell secretions
IL288509A (en) Mammalian cell culture
GB2489640B (en) Thin electrochemical cell
EP2719010A4 (en) MATERIALS FOR BATTERY ELECTROLYTE AND METHOD FOR THEIR USE
SG10201608341XA (en) Cd40l expressing mammalian cells and their use
IL225635A0 (en) Supplement for cell culture
LT2785359T (lt) Mezenchiminės stromos ląstelės ir su jomis susiję naudojimo būdai
EP2709128A4 (en) ELECTROCHEMICAL CELL
EP2732531A4 (en) SHORT-CIRCUIT DETECTION IN BATTERY CELLS
PL2782181T3 (pl) Ogniwo warstwowe i zmontowana bateria zawierająca ogniwo warstwowe
PL2534719T3 (pl) Ładowalne ogniwo elektrochemiczne
SG11201503579RA (en) Cell culture med
GB201100180D0 (en) Tumour cell and tissue culture
EP2555304A4 (en) BATTERY CELL
GB201118641D0 (en) Electrochemical cell
EP2709204A4 (en) OXYGEN CELL
EP2700707A4 (en) CELL CULTURE METHOD AND CELL CULTURE KIT
EP2777091A4 (en) RECHARGEABLE ELECTROCHEMICAL CELLS
HRP20200794T1 (hr) Keramidaza i diferencijacija stanica
EP2850117A4 (de) Novolak-basierte c-sn-materialien, ihre herstellung und ihre verwendung in elektrochemischen zellen
GB201120164D0 (en) Electrochemical cells and components thereof
GB201101423D0 (en) Membrane-divided electrochemical cells
GB201001991D0 (en) Thin electrochemical cell
EP2745343A4 (en) FUEL CELL AND MEMBRANE FOR THIS
GB201019779D0 (en) Electrochemical cells and components thereof